Regional Workshop on Access to Medicines and Intellectual Property Rights, 18-19 September, 2019
Event details
The South Centre and the Centre for Policy Analysis and Development, Ministry of Foreign Affairs, Republic of Indonesia are organizing a two-day regional seminar for policymakers for sharing experiences about policy options pursued by relevant agencies at the global, regional and national levels to make full use of the TRIPS flexibilities to support access to medicines. This seminar will share and assess the experience of negotiations related to intellectual property (IP) and access to medicines in the World Intellectual Property Organization, the World Health Organization and the World Trade Organization, as well as debates in several other international fora with policymakers from ministries of health, foreign affairs, trade and commerce, industry and national IP authorities from the South and South East Asia region, including participants from the ASEAN countries and the OIC. The seminar address key themes relevant to the contemporary IP and public health agenda in the South and South East Asia region and around the world, with a focus on TRIPS-consistent measures that may be adopted for enabling access to affordable medicines and on the role of different government departments in designing and implementing such measures.
Supporting Material
- Programme
- Concept Note
- Tackling the Proliferation of Patents: How to Avoid Undue Limitations to Competition and the Public Domain
- Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
- Access to Medicines: Experiences with Compulsory Licenses and Government use - The Case of Hepatitis C
- Patent Examination and Legal Fictions: How Rights are Created on Feet of Clay
- Guidelines on Patentability and Access to Medicines
- Implementing Pro-Competitive Criteria for the Examination of Pharmaceutical Patents
- The issue of IP, public health & access to medicines in international organizations
- Flexibilities in the Examination of Pharmaceutical Patent Applications
- Patents and Access to Medicines in Asia
- TRIPS Flexibilities in National Patent Laws
- TRIPS Plus Provisions in FTAs